Regina Altizer

Regina Stanton Altizer currently serves as the Senior Associate Director of Public Policy at Boehringer Ingelheim since July 2023. Previously, Regina held various positions at Bristol Myers Squibb, including Therapeutic Policy for Hematology and Senior Manager of State Policy from May 2022 to July 2023. At Adaptive Biotechnologies Corp., Regina worked as a Health Policy Analyst in External Affairs between August 2021 and March 2022. Regina's experience also includes roles as a Health Policy Analyst and Public Policy and Government Affairs Graduate Fellow at Regeneron from June 2019 to July 2021. Regina began professional experience as a Clinical Systems Analyst Intern at Centra Health and served as a Development Intern at the Melanoma Research Foundation. Regina holds a Master of Public Health with a focus on Health Policy from The George Washington University-Milken Institute School of Public Health and a Bachelor of Science in Biological Sciences with a minor in ILRM from Virginia Tech.